# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019, Regulation 165: Amendment of regulation 204 (obligation on licensing authority in relation to public announcements)

Extent: E+W+S+N.I.

In regulation 204 , in paragraph (1), after “pharmacovigilance concerns” insert “which relate to products authorised under a UKMA(NI) or UKMA(UK).

---
Source: https://www.legislation.gov.uk/uksi/2019/775/regulation/165 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2019/regulation-165
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.